Molecular characterization for neurodevelopmental disorders by chromosomal microarray analysis
10.3760/cma.j.issn.1009-9158.2016.04.004
- VernacularTitle:染色体芯片分析对神经发育性疾病的分子诊断率研究
- Author:
Xin LIU
;
Hongjing LIU
;
Li WANG
;
Ke LI
;
Mengying LI
;
Juan GENG
;
Fei LI
- Publication Type:Journal Article
- Keywords:
Neurologic examination;
DNA copy number variations;
Microarray analysis;
Genotype;
Molecular diagnostic techniques
- From:
Chinese Journal of Laboratory Medicine
2016;39(4):246-250
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the diagnostic yields of clinical chromosomal microarray ( CMA) testing for patients with neurodevelopmetal disorders ( NDD) , and to characterize the spectrum of pathogenic copy number variation(CNV) in NDD.Methods The study was a cross-sectional study.NDD patients from Shanghai Children′s Medical Center ( SCMC ) from April 2014 to April 2015 were recruited.DNA samples from SCMC cohort were tested on Affymetrix Cytoscan Dx microarray platform.The diagnostic yields of CMA testing were further assessed for the whole NDD cohort and each subgroup.Results A genome-wide genotype-phenotype analysis on a total of 107 NDD cases with CMA testing was conducted.Based on the SCMC clinical cohort, the overall diagnostic yield of CMA testing for NDD patients was 20.6%(22/107). Excluding one case with chromosomal aneuploid, the frequency of non-polymorphic CNVs of the rest NDD cases were 25.5%(27/106).The diagnostic yield for developmental delay/intellectual disorder(DD/ID) and autism spectrum disorder(ASD)were 26.3% (15/57) and 10.2%(4/39) respectively.DD/ID was more likely to be associated with CNV than ASD and attention-deficit/hyperactivity disorder(ADHD).Five recurrent genomic loci were significantly enriched in patients including 1q21.1-q21.2, 15q11.2-q13.1, 22q11.2, 7q11.23 and 17q11.2.Conclusion CNV is an important pathogenesis in NDD.
